CN108030088A - A kind of preparation method of protein modified phytosterol liposome powder - Google Patents
A kind of preparation method of protein modified phytosterol liposome powder Download PDFInfo
- Publication number
- CN108030088A CN108030088A CN201711020091.5A CN201711020091A CN108030088A CN 108030088 A CN108030088 A CN 108030088A CN 201711020091 A CN201711020091 A CN 201711020091A CN 108030088 A CN108030088 A CN 108030088A
- Authority
- CN
- China
- Prior art keywords
- phytosterol
- liposome
- preparation
- protein modified
- lecithin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 58
- 239000000843 powder Substances 0.000 title claims abstract description 31
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 76
- 239000000787 lecithin Substances 0.000 claims abstract description 30
- 229940067606 lecithin Drugs 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000018102 proteins Nutrition 0.000 claims abstract description 29
- 235000019441 ethanol Nutrition 0.000 claims abstract description 24
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 23
- 235000010445 lecithin Nutrition 0.000 claims abstract description 23
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 16
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 16
- 239000006185 dispersion Substances 0.000 claims abstract description 15
- 238000002390 rotary evaporation Methods 0.000 claims abstract description 13
- 239000012071 phase Substances 0.000 claims abstract description 12
- 239000012074 organic phase Substances 0.000 claims abstract description 7
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 10
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 3
- 229940083466 soybean lecithin Drugs 0.000 claims description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 2
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 claims description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 2
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 claims description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 2
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 claims description 2
- 235000004420 brassicasterol Nutrition 0.000 claims description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 2
- 235000000431 campesterol Nutrition 0.000 claims description 2
- 238000000265 homogenisation Methods 0.000 claims description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 2
- 235000016831 stigmasterol Nutrition 0.000 claims description 2
- 229940032091 stigmasterol Drugs 0.000 claims description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 9
- 238000001035 drying Methods 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000001603 reducing effect Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 239000002245 particle Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000002105 nanoparticle Substances 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012460 protein solution Substances 0.000 description 7
- -1 alcohol compound Chemical class 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000002378 plant sterols Nutrition 0.000 description 4
- 150000003432 sterols Chemical class 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- XIIAYQZJNBULGD-XWLABEFZSA-N 5α-cholestane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 XIIAYQZJNBULGD-XWLABEFZSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of preparation method of protein modified phytosterol liposome powder, solves the problems, such as phytosterol poorly water-soluble, the blood fat reducing function of phytosterol needs to be further improved.Phytosterol and lecithin are added in absolute ethyl alcohol by this method, dissolving are stirred at room temperature, up to organic phase;Soybean protein isolate is soluble in water, obtains water phase, and organic phase is slowly injected into water mutually under the conditions of high speed dispersion and high speed dispersion mixes, dry after high-pressure homogeneous, rotary evaporation removes ethanol to obtain through protein modified phytosterol liposome powder.Present invention process is simple, it is time-consuming few, selected materials safety environmental protection, gained liposome stability is good, and embedding rate is high, significantly improve the water solubility of phytosterol, solubility is good after liposome drying, and solubility is high, can preserve for a long time, it can be widely applied in food and medicine, to reduce the generation of hyperlipemia.
Description
Technical field
The present invention relates to a kind of food additives field, specifically a kind of protein modified phytosterol liposome powder
Preparation method.
Background technology
Phytosterol, is the functional lipids with class cholesterol structure being present in plant, is steroid in plant
The general designation of alcohol compound.Phytosterol is white crystalline powder or particle at normal temperatures, odorless, tasteless, fusing point up to 130~
170 DEG C, not soluble in water, strong acid and highly basic dissolve in a variety of organic solvents, such as acetone, absolute ethyl alcohol, ether, benzene, chloroform, stone
Oily ether etc..
Nineteen fifty-three, Pollak discoveries can treat high-cholesterol disease by taking in phytosterol, plant opened from this
The research that sterol is applied in norcholesterol.The discoveries such as Lees daily intake content of phytosterol and reach 3g with regard to that can reach best drop
Cholesterol effect, can reduce about 12% cholesterol, and is tested and confirmed by follow-up clinical.Plant steroid after emulsification
More preferably, Richard has found that 1g phytosterols its blood fat reducing function after the emulsification of 300mg lecithin is swum for 1g to alcohol norcholesterol effect
From as many as 3 times of phytosterol, 36.7% can reach.
At present, the plant sterol product occurred both at home and abroad is varied, it is contemplated that natural phytosterin dissolubility is poor, fusing point
The problems such as height, poor taste, often to its it is modified be then added in food, but modifying process often take, effort, and conversion ratio compared with
Low, production cost is high.Also have and improve phytosterol in water by preparing the means such as o/w lotions, nanoparticle, cyclodextrin embedding
Dissolubility, but still it is difficult to reach higher embedding rate and load rate, solubility is not high in water, and stability, solubility are poor, add
There are security risk for some synthetic emulsifiers added.
United States Patent (USP) 7,678,405 discloses the preparation method of a plant sterols o/w lotions, with xanthans, carragheen,
The edible oil such as the compound emulsifying agents such as sucrose ester, agar and polyglycerol ester, addition corn oil, soybean oil, rapeseed oil is cooked oil phase preparation
Phytosterol o/w lotions, selected phytosterol exist with esterified form mostly, comprise only free phytosterol on a small quantity.The U.S.
Patent 6,113, the 972 invention preparation method of one plant sterols-albumen composition, using albumen as wall material, and is aided with single sweet
The emulsifying agent such as ester and lecithin, phytosterol is dissolved in oil, prepares stable phytosterol-albumen microcapsules.Chinese patent
Phytosterol is dissolved in oil phase by 101991160A, in a heated condition with sucrose fatty ester, Glycerin, mixed triester with caprylic acid capric acid and poly- sweet
Oil and fat acid esters etc. emulsifies phytosterol, prepares phytosterol water-based beverage.The above method needs addition oil in preparation process
Phytosterol meltage is mutually improved, but the Excess free enthalpy of oil will also result in lipids contents rise, can not reach preferable lipid-loweringing
Effect.
Liposome is as a kind of pharmaceutical carrier, available for embedding various water-soluble or oil soluble materials.In liposome preparation
During, often adding cholesterol improves phosphatide membrane structure, improves liposome stability.Phytosterol is similar to cholesterol structure,
Have been found to may replace preparation of the cholesterol for liposome, and cholesterol in human body content can be reduced.Liposome can be made
Into two kinds of forms of lotion and powder, for lotion, powder is not only more convenient storage and transport, but also from addition object shape
State (liquid or solid-state) influences, can be freely in various aqueous foods, in the non-aqueous food such as cake, candy, biscuit and oatmeal
It can also be added in product, therefore prepare powder there are more preferable market prospects.Liposome drying need to be added big frequently with freeze-drying
Freeze drying protectant is measured, to improve the solubility of liposome, significantly reduces drugloading rate.
With 3 kinds of common water-solubility protein (soybean protein isolate, Whey Protein Concentrate and junket in Chinese patent 105410934A
Protein acid sodium) it is emulsifying agent, phytosterol is dissolved in n-hexane, water-solubility protein-plant steroid is prepared by emulsifying evaporation
Alcohol nano particle.This method is easy to operate, improves the solubility of nano particle.But the technical solution is dredged with water-solubility protein
The water base direct embedded plant sterol of group, in the drying process since unfreezing can destroy nanoparticle structure, embedding rate reduces;Together
When nanoparticle in phytosterol solubility it is still relatively low by water-solubility protein solubility limit, solubility in water.Peng Jie is used
The anti-solvent precipitation method prepare phytosterol nanoparticle, are received respectively with soybean 7 S globulin and casein embedded plant sterol, gained
Phytosterol solubility reaches 1.17mg/mL to grain of rice solubility in below 1mg/mL, sucrose ester embedding gained nanoparticle, but
Particle diameter is more than 2 μm;Wen Juan embeds phytosterol using hydroxypropyl cyclodextrin, the solubility of phytosterol in inclusion compound
It can reach 0.466mg/mL.Phytosterol solubility is had a great influence by coating wall material, therefore selects suitable emulsifying agent or wall material
It is good to obtaining a kind of solubility, it is particularly important that solubility high phytosterol preparation.
The content of the invention
The purpose of the present invention is in order to solve the above-mentioned technical problem, there is provided a kind of technique is simple, derives from a wealth of sources, production cost
The preparation method of protein modified phytosterol liposome powder low, control is easy, the product cut size of production is small, solubility is good,
Solubility is high, has excellent lipid-lowering effect.
Technical solution includes the following steps:
(1) lecithin and phytosterol are according to 2~6:The ratio of 1 (w/w) is added in absolute ethyl alcohol, makes phytosterol dense
Spend for 0.5%~4% (w/v), dissolving is stirred at room temperature, prepare organic phase;
(2) soybean protein isolate is added in deionized water, it is 0.5%~4% (w/ to make soybean protein isolate concentration
V), water phase is prepared after dissolving aquation is stirred at room temperature;
(3) according to volume ratio 1:Organic phase is slowly injected into water phase by 1~10 ratio, and high speed dispersion mixes;Then
Repeatedly it is high-pressure homogeneous after obtain protein modified phytosterol liposome;
(4) phytosterol liposome rotary evaporation obtained by step (3) is removed into ethanol, freeze-drying or spray drying, obtained
To freeze-dried powder or spray powder.
The phytosterol is at least one of cupreol, stigmasterol, campesterol or brassicasterol.
The lecithin is soybean lecithin or egg yolk lecithin.
Water phase is made in the adjusting pH to 7.0 after dissolving is stirred at room temperature, 4 DEG C of aquations overnight.
The high speed dispersion time described in step (3) is 1~5min, and rotating speed is 8000~15000r/min.
High-pressure homogeneous pressure described in step (3) is 40~100MPa, and homogenization cycles are 2~8 times.
It is that 38~45 DEG C of rotary evaporations remove under 0.08~0.13MPa vacuums that ethanol described in step (4), which removes mode,
Go.
Inventor just improves the problems such as phytosterol is water-soluble and conducts in-depth research, and has carried out following improvement, and (1) is adopted
With the compounding of phytosterol and lecithin, using the emulsification of lecithin, make phytosterol nanosizing, solve it in water not
The problem of molten;(2) phytosterol can effectively reduce T-CHOL and low density lipoprotein cholesterol content in blood fat, and rise is highly dense
The effect of lipoprotein is spent, but it is invalid to triglycerides, and the lecithin arranged in pairs or groups is effective to triglycerides, has blood fat reducing function,
So as to fulfill invented liposomes to triglycerides, regulation and control effect of T-CHOL and low density lipoprotein cholesterol;(3) first will
Phytosterol and lecithin are combined into the less liposome of particle diameter, are re-introduced into soybean protein isolate, using albumen and lecithin it
Between existing hydrophobic effect and electrostatic interaction, be combined with each other, (not direct to be combined with phytosterol), so as to further improve plant
The stability of sterol liposome, moreover it is possible to greatly improve product solubility.Wherein, in order to ensure embedding of the lecithin to phytosterol
Effect and load rate, lecithin are 2~6 with phytosterol by weight ratio:1 (w/w), the excessive load rate that can reduce phytosterol,
The too low embedding effect that can influence phytosterol, liposomal particle size are bigger than normal.The organic solvent is absolute ethyl alcohol, organic phase and water
The mixing ratio of phase is 1:1~10, proportion of ethanol too plantlet sterol dissolving it is insufficient, easily separated out in dispersion process, it is excessive then
Easily cause a large amount of albuminous degenerations, influence to embed effect.
Gained beneficial effects of the present invention are as follows:
The present invention is using natural phytosterin and soybean lecithin as raw material, using absolute ethyl alcohol as solvent, soybean protein isolate
For protective agent, protein modified phytosterol liposome is prepared using alcohol injection, not only increases the dissolubility of phytosterol,
Also arrange in pairs or groups triglyceride reducing effect of lecithin, realize more preferable lipid-lowering effect, and improve the stability of liposome with again
Dispersiveness.Selected raw material sources extensively, securely and reliably, are suitable for industrialized production and application.Products obtained therefrom particle diameter is small, dissolubility
Good, embedding rate height, can be added in the industries such as food, medicine as additive, be particularly suitable for people with hyperlipidemia, have extensive
Application prospect.
Embodiment
Embodiment 1
(1) lecithin and phytosterol are pressed 4:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
1% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 1% (w/v) ratio, is stirred at room temperature dissolving, adjust pH to
7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:The phytosterol that 4 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 10000r/min high speed dispersions 5min;Then high-pressure homogeneous 8 times under 80MPa
To protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.11MPa vacuums, 40 DEG C of rotary evaporations remove ethanol,
Freeze-drying, obtains freeze-dried powder.
Embodiment 2
(1) lecithin and phytosterol are pressed 3:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
2% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 1% (w/v) ratio, is stirred at room temperature dissolving, adjust pH to
7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:The phytosterol that 4 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 10000r/min high speed dispersions 3min;Then high-pressure homogeneous 4 times under 90MPa
To protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.13MPa vacuums, 40 DEG C of rotary evaporations remove ethanol,
Freeze-drying, obtains freeze-dried powder.
Embodiment 3
(1) lecithin and phytosterol are pressed 4:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
4% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 0.5% (w/v) ratio, dissolving is stirred at room temperature, adjust pH
Stayed overnight to 7.0,4 DEG C of aquations;
(3) according to volume ratio 1:The phytosterol that 4 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 8000r/min high speed dispersions 5min;Then high-pressure homogeneous 4 times under 80MPa
To protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.11MPa vacuums, 45 DEG C of rotary evaporations remove ethanol,
Freeze-drying, obtains freeze-dried powder.
Embodiment 4
(1) lecithin and phytosterol are pressed 2:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
2% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 1% (w/v) ratio, is stirred at room temperature dissolving, adjust pH to
7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:The phytosterol that 2 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 10000r/min high speed dispersions 5min;Then high-pressure homogeneous 6 times under 90MPa
To protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.11MPa vacuums, 40 DEG C of rotary evaporations remove ethanol,
Freeze-drying, obtains freeze-dried powder.
Embodiment 5
(1) lecithin and phytosterol are pressed 6:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
2% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 0.75% (w/v) ratio, dissolving is stirred at room temperature, adjusted
PH to 7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:The phytosterol that 10 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 15000r/min high speed dispersions 1min;Then high-pressure homogeneous 6 times under 100MPa
Obtain protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.11MPa vacuums, 38 DEG C of rotary evaporations remove ethanol,
In 70 DEG C of inlet temperature, 55 DEG C of outlet temperature, is spray-dried under 0.4MPa vacuums, obtains spray powder.
Embodiment 6
(1) lecithin and phytosterol are pressed 2:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
1% (w/v), is stirred at room temperature dissolving;
(2) soybean protein isolate is added in deionized water in 4% (w/v) ratio, is stirred at room temperature dissolving, adjust pH to
7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:The phytosterol that 4 ratio obtains step (1)-lecithin ethanol solution is slowly injected into
In the protein solution that step (2) obtains, and in 10000r/min high speed dispersions 3min;Then high-pressure homogeneous 8 times under 40MPa
To protein modified phytosterol liposome;
(4) by phytosterol liposome obtained by step (3) under 0.08MPa vacuums, 40 DEG C of rotary evaporations remove ethanol,
In 70 DEG C of inlet temperature, 55 DEG C of outlet temperature, is spray-dried under 0.4MPa vacuums, obtains spray powder.
Comparative example 7
(1) lecithin and phytosterol are pressed 4:1 (w/w) ratio is added in absolute ethyl alcohol, makes the phytosterol concentration be
1% (w/v), is stirred at room temperature dissolving;
(2) according to volume ratio 1:Phytosterol-lecithin ethanol solution is slowly injected into deionized water by 4 ratio, and
In 10000r/min high speed dispersions 3min;Then phytosterol liposome is obtained high-pressure homogeneous 6 times under 80MPa;
(3) by phytosterol liposome obtained by step (2) under 0.09MPa vacuums, 40 DEG C of rotary evaporations remove ethanol,
Freeze-drying, obtains freeze-dried powder.
Comparative example 8
(1) phytosterol is pressed 5:1 (w/w) ratio is added in n-hexane, and 45 DEG C of stirring and dissolvings, it is molten to obtain phytosterol
Liquid;
(2) soybean protein isolate is added in deionized water in 1% (w/v) ratio, is stirred at room temperature dissolving, adjust pH to
7.0,4 DEG C of aquations are stayed overnight;
(3) according to volume ratio 1:Phytosterol solution is slowly injected into protein solution by 10 ratio, and in 10000r/
Min high speed dispersions 3min;Then phytosterol nano particle is obtained high-pressure homogeneous 6 times under 80MPa;
(4) by phytosterol nano particle obtained by step (3) under 0.09MPa vacuums, 40 DEG C of rotary evaporations remove just
Hexane, freeze-drying, obtains freeze-dried powder.
Malvern ParticleSizer measures front and rear particle diameter, pdI and the current potential size of phytosterol liposome drying:Liposome dilutes
Particle diameter is measured after 200 times, current potential is measured after 20 times of dilution;Dried powder is dissolved with 1mg/ml, is measured current potential, is surveyed after 10 times of dilution
Determine particle diameter, the results are shown in Table 1:
Physicochemical property characterizes before and after the protein modified phytosterol liposome drying of table 1
Gas phase analysis content of phytosterol:The liposome of preparation is centrifuged into 20min in 8000g, 200 μ l of supernatant is taken, adds
It is internal standard to enter 200 μ l1mg/ml5 α-cholestane, adds 10ml1mol/l KOH ethanol solutions, and 80 DEG C of saponification 1h, add 5ml water,
10ml n-hexane extractions, take supernatant to wash 3 times, nitrogen is blown, BSTFA70 DEG C of derivative 1h, gas phase analysis content of phytosterol.It is dry
Liposome powder is dissolved with 20mg/ml afterwards, and 8000g centrifugation 20min, take supernatant to measure content of phytosterol in the same way.
The front and rear embedding rate of protein modified phytosterol liposome drying and load rate are as shown in table 2:
The liposome embedded rate of 2 phytosterol of table and load rate
Conclusion:Phytosterol liposomal particle size described in comparative example 7 is 72.71nm, and pdI 0.155, current potential is -34.8, fat
Plastid particle diameter distribution is uniform, and stability is good;After liposome is freeze-dried, solubility is poor, and particle diameter has bright in more than 2000nm
Aobvious insoluble matter.Protein modified phytosterol liposome described in embodiment has a little increase compared with proliposome particle diameter, but stability with
Dispersiveness does not change;Liposome solubility is good after freeze-dried or spray drying, phytosterol bag in section Example
Bury rate and still can reach more than 85%.Illustrate that lecithin works well phytosterol inclusion;Soybean protein isolate can effectively improve
The solubility and stability of phytosterol liposome, improve the water solubility of phytosterol.8 the method for comparative example is separated with soybean
Albumen prepares phytosterol nanoparticle, and products obtained therefrom solubility is good, but the solubility of phytosterol is still relatively low;Through protein modified plant
Thing sterol liposome solves the problems, such as this, and not only solubility is changed the liposome after freeze-dried or spray drying
Kind, the solubility of products obtained therefrom phytosterol is in more than 1.5mg/mL.
Claims (7)
1. a kind of preparation method of protein modified phytosterol liposome powder, it is characterised in that comprise the following steps that:
(1) lecithin and phytosterol are according to 2~6:The ratio of 1 (w/w) is added in absolute ethyl alcohol, makes the phytosterol concentration be
0.5%~4% (w/v), is stirred at room temperature dissolving, prepares organic phase;
(2) soybean protein isolate is added in deionized water, soybean protein isolate is 0.5%~4% (w/v), is stirred at room temperature
Water phase is prepared after dissolving, aquation;
(3) according to volume ratio 1:Organic phase is slowly injected into water phase by 1~10 ratio, and high speed dispersion mixes;Then it is multiple
Protein modified phytosterol liposome is obtained after high-pressure homogeneous;
(4) phytosterol liposome rotary evaporation obtained by step (3) is removed into ethanol, freeze-drying or spray drying, is frozen
Dry powder or spray powder.
2. the preparation method of protein modified phytosterol liposome powder according to claim 1, it is characterised in that described
Phytosterol at least one of for cupreol, stigmasterol, campesterol or brassicasterol.
3. the preparation method of protein modified phytosterol liposome powder according to claim 1, it is characterised in that described
Lecithin is soybean lecithin or egg yolk lecithin.
4. the preparation method of protein modified phytosterol liposome powder according to claim 1, it is characterised in that step
(2) in, water phase is made in the adjusting pH to 7.0 after dissolving is stirred at room temperature, 4 DEG C of aquations overnight.
5. the preparation method of protein modified phytosterol liposome powder according to claim 1, it is characterised in that step
(3) high speed dispersion time described in is 1~5min, and rotating speed is 8000~15000r/min.
6. the preparation method of protein modified phytosterol liposome powder according to claim 1 or 5, it is characterised in that
High-pressure homogeneous pressure described in step (3) is 40~100MPa, and homogenization cycles are 2~8 times.
7. according to the preparation method of the protein modified phytosterol liposome powder of claim 1-5 any one of them, its feature
It is, it is under 0.08~0.13MPa vacuums that ethanol described in step (4), which removes mode, and 38~45 DEG C of rotary evaporations remove.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711020091.5A CN108030088B (en) | 2017-10-26 | 2017-10-26 | Preparation method of protein-modified phytosterol liposome powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711020091.5A CN108030088B (en) | 2017-10-26 | 2017-10-26 | Preparation method of protein-modified phytosterol liposome powder |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108030088A true CN108030088A (en) | 2018-05-15 |
CN108030088B CN108030088B (en) | 2021-05-28 |
Family
ID=62092580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711020091.5A Active CN108030088B (en) | 2017-10-26 | 2017-10-26 | Preparation method of protein-modified phytosterol liposome powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108030088B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110192651A (en) * | 2019-05-31 | 2019-09-03 | 浙江工业大学 | A kind of preparation method of the nanoemulsions using soybean protein isolate load phytosterin ester |
CN110250518A (en) * | 2019-07-31 | 2019-09-20 | 江南大学 | A kind of preparation method of water-soluble plant sterols nano particle |
CN110946285A (en) * | 2019-11-29 | 2020-04-03 | 暨南大学 | Preparation method of water-in-oil Pickering emulsion based on phytosterol stabilization |
CN112956680A (en) * | 2021-02-10 | 2021-06-15 | 青岛农业大学 | Plant oil body-imitated core-shell liposome and preparation method thereof |
CN113317508A (en) * | 2021-05-28 | 2021-08-31 | 华南理工大学 | Water-soluble phytosterol nanoparticles and preparation method thereof |
CN113967192A (en) * | 2021-11-09 | 2022-01-25 | 陕西海斯夫生物工程有限公司 | Pharmaceutical composition for accelerating wound healing, preparation method and application thereof |
CN113973930A (en) * | 2021-11-03 | 2022-01-28 | 江南大学 | Massive fat simulant based on long-chain fatty acid liposome and preparation method thereof |
CN114403449A (en) * | 2022-01-19 | 2022-04-29 | 浙江大学 | Protein-sterol covalent complex and preparation method and application thereof |
CN114601920A (en) * | 2022-03-23 | 2022-06-10 | 宁波御坊堂生物科技有限公司 | Oral liposome composition for improving bone joint health and preparation method thereof |
CN114989572A (en) * | 2022-05-06 | 2022-09-02 | 上海同新服材新材料科技有限公司 | Degradable tracer masterbatch, preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004359647A (en) * | 2003-06-09 | 2004-12-24 | Sunstar Inc | Lyposome-containing composition for oral administration |
CN101176720A (en) * | 2006-11-09 | 2008-05-14 | 刘祥华 | Ligustrazine microcosmic salt liposome medicine and preparing method |
CN101670112A (en) * | 2008-08-11 | 2010-03-17 | 苏州世林医药技术发展有限公司 | Stable albumins lipid medicine carrying system and preparation method thereof |
CN103494773A (en) * | 2013-10-12 | 2014-01-08 | 南京医科大学 | ZL006 liposome and preparation method thereof |
CN104083326A (en) * | 2014-07-17 | 2014-10-08 | 沈阳药科大学 | Method for preparing lipidosome coated with protein drugs |
-
2017
- 2017-10-26 CN CN201711020091.5A patent/CN108030088B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004359647A (en) * | 2003-06-09 | 2004-12-24 | Sunstar Inc | Lyposome-containing composition for oral administration |
CN101176720A (en) * | 2006-11-09 | 2008-05-14 | 刘祥华 | Ligustrazine microcosmic salt liposome medicine and preparing method |
CN101670112A (en) * | 2008-08-11 | 2010-03-17 | 苏州世林医药技术发展有限公司 | Stable albumins lipid medicine carrying system and preparation method thereof |
CN103494773A (en) * | 2013-10-12 | 2014-01-08 | 南京医科大学 | ZL006 liposome and preparation method thereof |
CN104083326A (en) * | 2014-07-17 | 2014-10-08 | 沈阳药科大学 | Method for preparing lipidosome coated with protein drugs |
Non-Patent Citations (2)
Title |
---|
吴韶敏等: "脂质体技术应用于食品工业的最新研究进展 ", 《中国油脂》 * |
王欢等: "大豆分离蛋白-磷脂复合乳化体系的制备及pH对其影响的研究 ", 《食品工业科技》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110192651A (en) * | 2019-05-31 | 2019-09-03 | 浙江工业大学 | A kind of preparation method of the nanoemulsions using soybean protein isolate load phytosterin ester |
CN110250518A (en) * | 2019-07-31 | 2019-09-20 | 江南大学 | A kind of preparation method of water-soluble plant sterols nano particle |
CN110946285A (en) * | 2019-11-29 | 2020-04-03 | 暨南大学 | Preparation method of water-in-oil Pickering emulsion based on phytosterol stabilization |
WO2021104144A1 (en) * | 2019-11-29 | 2021-06-03 | 暨南大学 | Method for preparing oil-in-water pickering emulsion based on phytosterol stability |
CN112956680A (en) * | 2021-02-10 | 2021-06-15 | 青岛农业大学 | Plant oil body-imitated core-shell liposome and preparation method thereof |
CN113317508A (en) * | 2021-05-28 | 2021-08-31 | 华南理工大学 | Water-soluble phytosterol nanoparticles and preparation method thereof |
CN113973930A (en) * | 2021-11-03 | 2022-01-28 | 江南大学 | Massive fat simulant based on long-chain fatty acid liposome and preparation method thereof |
CN113967192A (en) * | 2021-11-09 | 2022-01-25 | 陕西海斯夫生物工程有限公司 | Pharmaceutical composition for accelerating wound healing, preparation method and application thereof |
CN114403449A (en) * | 2022-01-19 | 2022-04-29 | 浙江大学 | Protein-sterol covalent complex and preparation method and application thereof |
CN114601920A (en) * | 2022-03-23 | 2022-06-10 | 宁波御坊堂生物科技有限公司 | Oral liposome composition for improving bone joint health and preparation method thereof |
CN114989572A (en) * | 2022-05-06 | 2022-09-02 | 上海同新服材新材料科技有限公司 | Degradable tracer masterbatch, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108030088B (en) | 2021-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108030088A (en) | A kind of preparation method of protein modified phytosterol liposome powder | |
Sarabandi et al. | Protection of casein hydrolysates within nanoliposomes: Antioxidant and stability characterization | |
US8956676B2 (en) | Composition comprising protein and disperse fat | |
JP2002517418A (en) | Composition comprising phytosterol and / or phytostanol with enhanced solubility and dispersibility | |
CN105410934B (en) | A kind of water-solubility protein-phytosterol nano particle and preparation and application | |
JP2003514560A (en) | Phytosterol and phytostanol compositions | |
US20070104866A1 (en) | Encapsulated emulsions and methods of preparation | |
Jash et al. | Synthesis of multivitamin-loaded heat stable liposomes from milk fat globule membrane phospholipids by using a supercritical-CO 2 based system | |
Yucel et al. | Submicron complex lipid carriers for curcumin delivery to intestinal epithelial cells: Effect of different emulsifiers on bioaccessibility and cell uptake | |
KR100951706B1 (en) | Nanoemulsion, nanoparticle containing resveratrol and method of production thereof | |
JPH11188256A (en) | Oily composition and its production | |
Hou et al. | Effects of phytosterol butyrate ester on the characteristics of soybean phosphatidylcholine liposomes | |
Shahgholian | Encapsulation and Delivery of Nutraceuticals and Bioactive Compounds by Nanoliposomes and Tocosomes as Promising Nanocarriers | |
KR102393620B1 (en) | manufacturing method of nanoemulsion composition containing quercein and nanoemulsion composition containing quercein prepared using the method | |
CA2543697C (en) | Oil-in-water emulsified food product | |
MXPA04010923A (en) | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs. | |
KR101137281B1 (en) | Complex | |
CN109601994A (en) | A kind of preparation method of scallop protein isolate-beta carotene lotion | |
JP2012017326A (en) | Capsule for containing hardly soluble substance and method for manufacturing the same | |
JP2000024487A (en) | Emulsified composition containing oily composition | |
JPH05137506A (en) | Powdered fats and oils and its production | |
Li et al. | Preparation and characterization of Antarctic krill oil/quercetin co-loaded liposomes and their protective effect on oleic acid-induced steatosis and oxidative stress in vitro | |
JP2000026884A (en) | Powder composition containing oily composition | |
CN113317508A (en) | Water-soluble phytosterol nanoparticles and preparation method thereof | |
Wen et al. | New perspective on protein-based microcapsules as delivery vehicles for sensitive substances: A review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |